CHINA PHARMA HOLDINGS INC (CPHI) Stock Balance Sheet
NYSEARCA:CPHI - NYSE Arca - US16941T4013 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 412.70K | 626.90K | 1.42M | 2.03M | 4.86M | |||
| Receivables | 376.80K | 296.00K | 730.00K | 909.00K | 836.00K | |||
| Inventories | 1.98M | 2.27M | 3.73M | 2.95M | 3.34M | |||
| Other Current Assets | 82.50K | 81.30K | 110.00K | 78.00K | 59.00K | |||
| Total Current Assets | 2.85M | 3.27M | 6.00M | 5.96M | 9.09M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.80M | 4.92M | 7.22M | 10.01M | 13.41M | |||
| Intangibles | 6.57M | 6.70M | 3.25M | 1.81M | 148.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 11.37M | 11.62M | 10.47M | 11.82M | 13.56M | |||
| TOTAL ASSETS | 14.22M | 14.89M | 16.47M | 17.78M | 22.65M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 2.09M | 2.16M | 1.97M | 6.24M | 4.33M | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 215.00K | 286.50K | 377.00K | 445.00K | 384.00K | |||
| Accounts Payable | 548.30K | 225.10K | 966.00K | 667.00K | 927.00K | |||
| Other Current Liabilities | 2.27M | 2.35M | 3.51M | 5.39M | 4.87M | |||
| Total Current Liabilities | 5.12M | 5.02M | 6.82M | 12.74M | 10.51M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.39M | 1.39M | 1.41M | 0.00 | 5.25M | |||
| Deferred Taxes/Income | 732.20K | 731.20K | 742.00K | 755.00K | 824.00K | |||
| Other Non-Current Liabilities | N/A | N/A | 40.00K | 0.00 | 44.00K | |||
| Total Non-Current Liabilities | 2.13M | 2.12M | 2.19M | 755.00K | 6.12M | |||
| TOTAL LIABILITIES | 7.25M | 7.14M | 9.02M | 13.49M | 16.63M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -44.81M | -44.03M | -39.29M | -36.21M | -32.24M | |||
| Additional Paid In Capital | 40.63M | 40.60M | 35.28M | 28.85M | 25.64M | |||
| Common Shares | 3.30K | 32.60K | 11.00K | 75.00K | 47.00K | |||
| Other Shareholders' Equity | 11.15M | 11.14M | 11.45M | 11.57M | 12.56M | |||
| Shares Outstanding | 3.26M | 3.26M | 1.06M | 149.80K | 94.70K | |||
| Tangible Book Value per Share | 0.12 | 0.32 | 3.95 | 16.57 | 62.00 | |||
| Total Shareholders' Equity | 6.97M | 7.75M | 7.46M | 4.29M | 6.02M | |||
| TOTAL LIABILITIES AND EQUITY | 14.22M | 14.89M | 16.47M | 17.78M | 22.65M | |||
| Statistics | ||||||||
| Debt/Equity | 0.50 | 0.46 | 0.45 | N/A | 1.59 | |||
| Current Ratio | 0.56 | 0.65 | 0.88 | 0.47 | 0.86 | |||
| Return On Assets (ROA) | -32.12% | -31.81% | -18.70% | -22.34% | -15.01% | |||
| Return On Equity (ROE) | -65.51% | -61.13% | -41.30% | -92.61% | -56.48% | |||
All data in USD , ROIC based on taxRate of 0.21